Literature DB >> 14559815

Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.

Katsuhisa Noda1, Eiji Miyoshi, Jianguo Gu, Cong-Xiao Gao, Susumu Nakahara, Takatoshi Kitada, Koichi Honke, Kunio Suzuki, Harumasa Yoshihara, Kiyoshi Yoshikawa, Kiyoshi Kawano, Michela Tonetti, Akinori Kasahara, Masatsugu Hori, Norio Hayashi, Naoyuki Taniguchi.   

Abstract

The levels of fucosylated glycoproteins in various cancers and inflammatory processes have been a subject of intense study. The level of fucosyltransferases and intracellular GDP-L-fucose, a sugar nucleotide and a common donor substrate for all fucosyltransferases, may regulate the level of fucosylated glycoproteins. This study reports on the determination of GDP-L-fucose levels in human hepatocellular carcinoma (HCC) and surrounding tissues, using a recently established high-throughput assay system. Levels of GDP-L-fucose in HCC tissues were significantly increased compared with adjacent nontumor tissues or normal livers. The mean +/- SD for GDP-L-fucose level was 3.6 +/- 0.2 micro mol/mg in control liver, 4.6 +/- 0.9 micro mol/mg in adjacent noninvolved liver tissues (chronic hepatitis, 4.4 +/- 0.7 micro mol/mg; liver cirrhosis, 4.8 +/- 0.9 micro mol/mg), and 7.1 +/- 2.5 micro mol/mg in HCC tissues. The level of GDP-L-fucose in HCC decreased in proportion with tumor size (r = -0.675, P = 0.0002). When expression of the series of genes responsible for GDP-L-fucose synthesis was investigated, the gene expression of FX was found to be increased in 70% (7 of 10) of the HCC tissues examined compared with that in their surrounding tissues. The levels of GDP-L-fucose were positively correlated with the expression of FX mRNA (r = 0.599, P = 0.0074). The levels of FX gene expression in some human hepatoma and hepatocyte cell lines were determined. FX mRNA production was strongly increased in HepG2 and Chang liver, moderately increased in Hep3B and HLF, and, in HLE, was similar to that of a normal human liver tissue. To investigate the effect of GDP-L-fucose on core fucosylation, FX cDNA was transfected into Hep3B cells, which express a relatively low level of GDP-L-fucose:N-acetyl-beta-D-glucosaminide alpha1-6 fucosyltransferase (alpha1-6 FucT) and FX mRNA. Transfection of this gene caused an increase in GDP-L-fucose levels as well as the extent of fucosylation on glycoproteins, including alpha-fetoprotein, as judged by reactivity to lectins. Collectively, the results herein suggest that the high level of fucosylation in HCC is dependent on a high expression of FX followed by increases in GDP-L-fucose, as well as an enhancement in alpha1-6 FucT expression. Thus, an elevation in GDP-L-fucose levels and the up-regulation of FX expression represent potential markers for HCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559815

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.

Authors:  Patrick R Romano; Andrew Mackay; Minh Vong; Johann DeSa; Anne Lamontagne; Mary Ann Comunale; Julie Hafner; Timothy Block; Ryszard Lec; Anand Mehta
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

3.  Neural-specific α3-fucosylation of N-linked glycans in the Drosophila embryo requires fucosyltransferase A and influences developmental signaling associated with O-glycosylation.

Authors:  Dubravko Rendić; Mary Sharrow; Toshihiko Katoh; Bryan Overcarsh; Khoi Nguyen; Joseph Kapurch; Kazuhiro Aoki; Iain B H Wilson; Michael Tiemeyer
Journal:  Glycobiology       Date:  2010-08-05       Impact factor: 4.313

4.  Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma.

Authors:  Lucy Betesh; Mary Ann Comunale; Mengjun Wang; Hongyan Liang; Julie Hafner; Aykan Karabudak; Nasra H Giama; Catherine D Moser; Eiji Miyoshi; Lewis R Roberts; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2017-07-10       Impact factor: 3.494

5.  Assessment of serum L-fucose in brain tumor cases.

Authors:  S Manjula; Flama Monteiro; Annaya Rao Aroor; Suryanarayan Rao; Raja Annaswamy; Anjali Rao
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

6.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401

7.  Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Lucy Rodemich-Betesh; Julie Hafner; Mengjun Wang; Pamela Norton; Adrian M Di Bisceglie; Timothy Block; Anand Mehta
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

8.  Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Julie Hafner; Jonathan Krakover; Lucy Rodemich; Brent Kopenhaver; Ronald E Long; Omer Junaidi; Adrian M Di Bisceglie; Timothy M Block; Anand S Mehta
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

9.  Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Mengjun Wang; Ronald E Long; Mary Ann Comunale; Omer Junaidi; Jorge Marrero; Adrian M Di Bisceglie; Timothy M Block; Anand S Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

10.  N-linked glycosylation of the liver cancer biomarker GP73.

Authors:  Pamela A Norton; Mary Ann Comunale; Jonathan Krakover; Lucy Rodemich; Natalie Pirog; Anthony D'Amelio; Ramila Philip; Anand S Mehta; Timothy M Block
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.